EMPASIPRUBART
UNII PVA73UA67L

Substance Identification & Data

This profile provides standardized clinical and technical data for Empasiprubart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PVA73UA67L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2579031-19-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

PVA73UA67L

CAS Registry Number

2579031-19-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EMPASIPRUBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190478

National Cancer Institute reference terminology for clinical and research data.

INN ID

12277

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-180

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Empasiprubart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EMPASIPRUBART

Common Names & Synonyms

EMPASIPRUBART [INN]

EMPASIPRUBART [USAN]

IMMUNOGLOBULIN G1 (235-ALANINE,236-ALANINE,434-LYSINE,435-PHENYLALANINE), ANTI-(HUMAN COMPLEMENT COMPONENT 2) (HUMAN MONOCLONAL ARGX-117 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ARGX-117 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS C2 (COMPLEMENT 2)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-447) (VH HUMANIZED (HOMO SAPIENS IGHV1-8*01 (82.7%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT (8.8.11) (26-33.51-58.97-107)) (1-118) -HOMO SAPIENS IGHG1*01, G1M17,1, G1V14 CH2 A1.3, A1.2, G1V46 CH3 K113, F114 (CH1 K120 (215) (119-216), HINGE 1-15 (217-231), CH2 L1.3>A (235), L1.2>A (236) (232-341), CH3 D12 (357), L14 (359), H113>K (434), N114>F (435) (342-446), CHS K2>DEL (447)) (119-447)), (221-218')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-218') (V-KAPPA (HOMO SAPIENS IGKV4-1*01 (74.3%) -IGKJ2*01 (100%), CDR-IMGT (10.3.9) (27-36.54-56.93-101)) (1'-111') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (157), V101 (195) (112'-218')); DIMER (227-227'':230-230'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1SV LACKING THE GLUTAMINE SYNTHETASE (GS-KO) GENE, GLYCOFORM ALFA

Technical Codes

ARGX117

ARGX-117

External Clinical & Regulatory Resources

Previous UNIIPVA5FLE5K2

Next UNIIPVA9K5A6LT